Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Herbal-Antibiotic combo aims to beat stubborn womb infection

NCT ID NCT07485842

Disease control Sponsor: Tianjin Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding FuKe Qianjin capsules, a Chinese herbal remedy, to standard antibiotics works better than antibiotics alone for chronic endometritis, a womb infection that can cause infertility and miscarriage. About 300 women aged 20-40 will take either the herbal capsules or a placebo for 56 days, along with 14 days of doxycycline. Researchers will check if the infection clears and if pregnancy rates improve over 6 months of follow-up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
FuKe Qianjin Capsules (Chinese herbal preparation) plus doxycycline
What this could lead to
If successful, this combination could offer a more effective treatment for chronic endometritis, potentially improving fertility and reducing the need for repeated antibiotics.
What could go wrong
This is a Phase 4 trial, but it's still early to know if the herbal capsules add real benefit. The study is small and only in China, so results may not apply to everyone. Side effects from the herbs or antibiotics are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 40 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age range: 20 years old ≤ age ≤ 40 years old; 2. Meets the diagnostic criteria for chronic endometritis; 3. Meets the Traditional Chinese Medicine(TCM) syndrome differentiation criteria for damp-heat with deficiency of both qi and blood; 4. Has a regular menstrual cycle, with a cycle length ≥21 days and ≤35 days; 5. Voluntarily participates and signs the informed consent form. Exclusion Criteria: 1. Patients with concurrent acute genital tract and pelvic infections, etc. 2. Patients with endometrial tuberculosis, endometrial cancer, or other malignant gynecological tumors. 3. Patients with endometrial lesions, such as endometrial hyperplasia, uterine cavity adhesions, submucosal fibroids, or endometrial polyps. 4. Patients with hydrosalpinx or pelvic abscesses. 5. Patients with severe abnormalities in heart, liver, or kidney function. 6. Patients with uncontrolled autoimmune diseases (e.g., systemic lupus erythematosus, rheumatoid arthritis, etc.). 7. Patients with uncontrolled endocrine or metabolic diseases (e.g., diabetes, hyperthyroidism, or hypothyroidism, etc.). 8. Patients with mental disorders (e.g., severe depression, schizophrenia) or unable to comply with follow-up. 9. Pregnant or breastfeeding women, or those refusing contraception during treatment. 10. Patients with allergies to study drugs (including Chinese herbal components or antibiotics). 11. Patients who have participated in other clinical trials within the past 3 months. 12. Other situations where the investigator deems the patient unsuitable for participation in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic endometritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic endometritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic endometritis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tianjin Medical University General Hospital

    Tianjin, Tianjin Municipality, 300052, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.